In addition, high expression of GPX4 and GSS was significantly associated with a low overall survival rate in patients with CRC (Fig. S4I, J), potentially indicating oncogenic roles for Nrf2 pathway in CRC. This evidence concerns the gene NFE2L2 and colorectal carcinoma.